MannKind Corporation competitorsClear all

MannKind Corporation's top competitors include Lexicon Pharmaceuticals.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
MannKind Corporation
MannKind Corporation
MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
Founding Date
Founding Date
1991
Founding Date
1995
Type
Type
Public
Type
Public
Tags
Locations
Locations
Westlake Village, US HQ
Danbury, US
Locations
The Woodlands, US HQ
Jersey, JE
Atlanta, US
Birmingham, US
Boston, US
Charlotte, US
Chicago, US
see more
Employees
Employees
2323% increase
Employees
20216% increase
Valuation ($)
Valuation ($)
932.2 m
Valuation ($)
466 m
Twitter followers
Twitter followers
2.7 k
Twitter followers
259
Number of tweets (last 30 days)
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
4
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
13
Average likes per tweet (last 30 days)
1.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
75%
Employee Rating
Employee Rating
3.1
Employee Rating
3.5

Financial

Revenue (est.)
Revenue (est.)
$65.1m (FY, 2020)
Revenue (est.)
$322.1m (FY, 2019)
Cost of goods
Cost of goods
$15.1m (FY, 2020)
Cost of goods
$3.2m (FY, 2019)
Gross profit
Gross profit
$50.1m (FY, 2020)
Gross profit
$318.8m (FY, 2019)
Net income
Net income
($57.2m) (FY, 2020)
Net income
$130.1m (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 200m
Total funding raised
$ 244.7m
For sources of this data, please see the company profile

View company profiles

Lexicon Pharmaceuticals
HQ
The Woodlands, US
Employees
202↑ 16% increase

Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.

View company